4//SEC Filing
Backenroth Samuel 4
Accession 0001104659-20-140594
CIK 0001173281other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 5:01 PM ET
Size
5.7 KB
Accession
0001104659-20-140594
Insider Transaction Report
Form 4
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
- Award
Stock option (right to buy)
2020-12-29+41,915→ 41,915 totalExercise: $6.92Exp: 2030-12-29→ Common Stock (41,915 underlying)
Footnotes (1)
- [F1]25% of the total shares shall vest on the first anniversary of December 29, 2020, and the remaining shares shall vest on an equal monthly basis over the following 36 months.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001579887
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 5:01 PM ET
- Size
- 5.7 KB